- Delivering Pan India
Cyramza® (Ramucirumab) Ramucirumab 100 mg/10 mL and 500 mg/50 mL injection by Eli Lilly. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Ramucirumab 100 mg/10 mL, 500 mg/50 mL |
|---|---|
| Manufacturer | Eli Lilly |
| Country | United States |
| Pack size | 1 vial |
| Storage | Store refrigerated at 2°C to 8°C in the original carton, as stated on the label |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Cyramza® (Ramucirumab) 100 mg/10 mL and 500 mg/50 mL Injection: A Sourcing Guide for Hospitals and Pharmacies
Cyramza® is a ramucirumab injection (VEGFR2 antagonist) marketed by Eli Lilly. The decision to prescribe ramucirumab, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Cyramza® (ramucirumab) 100 mg/10 mL and 500 mg/50 mL injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the Cancer category. Supply is in bulk/wholesale quantities only.
Cyramza contains ramucirumab, a human monoclonal antibody supplied as a solution for intravenous infusion in single-dose vials of 100 mg/10 mL and 500 mg/50 mL, prepared and administered by healthcare professionals. Indications and use in India are those printed in the Indian pack insert.
How it works, according to the label: The US prescribing information (DailyMed) describes ramucirumab as a vascular endothelial growth factor receptor 2 (VEGFR2) antagonist.
The current US prescribing information for Cyramza (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Cyramza pack insert.
Published studies of ramucirumab include REGARD (Lancet 2014) and RAINBOW (Lancet Oncol 2014) in gastric cancer, REVEL (Lancet 2014) and RELAY (Lancet Oncol 2019) in lung cancer, RAISE (Lancet Oncol 2015) in colorectal cancer and REACH-2 (Lancet Oncol 2019) in hepatocellular carcinoma. Results and conclusions are those of the trial authors and the prescribing information; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack (confirm against the carton) |
|---|---|---|
| Ramucirumab 100 mg/10 mL | Solution for IV infusion | Single-dose vial (confirm against the carton) |
| Ramucirumab 500 mg/50 mL | Solution for IV infusion | Single-dose vial (confirm against the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, oncology centres, day-care infusion units and pharmacies in India that need to source Cyramza in bulk quantities from a licensed distributor.
Side effects are listed in the prescribing information and Indian pack insert and are not summarised here. Refer to the label and consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Store refrigerated at 2°C to 8°C in the original carton, protected from light, as directed on the pack. Do not freeze or shake.
Cyramza is marketed by Eli Lilly. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Cyramza through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Cyramza available in India?
A.K. Pharma supplies Cyramza® (ramucirumab) 100 mg/10 mL and 500 mg/50 mL injection to hospitals and pharmacies in India. Contact us for current availability.
What does Cyramza contain?
Cyramza contains ramucirumab, marketed by Eli Lilly. The details of use are those on its label.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
